tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Turkaly, 129 are a BUY (93.48%), 8 are a HOLD (5.8%), 1 are a SELL (0.72%).
Analyst David Turkaly, currently employed at JMP, carries an average stock price target met ratio of 35.84% that have a potential upside of 30.03% achieved within 226 days.
David Turkaly’s has documented 263 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GMED, Globus Medical at 27-May-2025.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 8/14/2024. The price target of $3 was fulfilled within 167 days with a profit of $2.17 (261.45%) receiving and performance score of 15.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
1 years 25 days ago
(15-Sep-2024)
3/3 (100%)
$1.8 (21.95%)
243
Buy
$4.5
$2.11 (88.28%)
$3
2 years 2 months ago
(10-Aug-2023)
14/16 (87.5%)
$-0.55 (-10.89%)
297
Buy
$9
$6.61 (276.57%)
$6
2 years 3 months 26 days ago
(14-Jun-2023)
2/3 (66.67%)
$2.05 (29.50%)
81
Buy
$17
$14.61 (611.30%)
$12
3 years 2 months 22 days ago
(18-Jul-2022)
0/2 (0%)
$8.43 (98.37%)
Which stock is David Turkaly is most bullish on?
Which stock is David Turkaly is most reserved on?
What Year was the first public recommendation made by David Turkaly?
